BioCentury
ARTICLE | Company News

Life Technologies sales and marketing update

October 1, 2012 7:00 AM UTC

Life Technologies launched its Pervenio Lung RS test in the U.S. to determine whether an early stage, non-squamous, non-small cell lung cancer (NSCLC) patient is at high, intermediate or low risk of ...